NACHT MARIUS → Protalix BioTherapeutics, Inc. PLX

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100

Passive Schedule 13G filer baseline
Moderate short days-to-cover (3.3 DTC)
Short interest building (+15.4% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 3.28

3,508,555 shares short · +15.4% vs prior

Other 13D/G Filings on Protalix BioTherapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-15	SCHEDULE 13G	HOLD Alapkezelo Zrt.	—	—	view →

Other Filings by NACHT MARIUS

Filed	Form	Issuer	Stake	Shares
2022-12-27	SC	BiondVax Pharmaceuticals Ltd. SCNI	—	—	view →
2022-01-11	SC	BiondVax Pharmaceuticals Ltd. SCNI	—	—	view →
2021-02-09	SC	BiondVax Pharmaceuticals Ltd. SCNI	—	—	view →
2019-11-12	SC	BiondVax Pharmaceuticals Ltd. SCNI	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →